{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:13:38Z","timestamp":1792113218323,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG013730"],"award-info":[{"award-number":["RF1AG013730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020940","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016220","name":"Georgia Clinical and Translational Science Alliance","doi-asserted-by":"publisher","award":["#UL1 TR002345"],"award-info":[{"award-number":["#UL1 TR002345"]}],"id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.expneurol.2024.115068","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T23:59:05Z","timestamp":1732579145000},"page":"115068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Two cardinal features of ALS, reduced STMN2 and pathogenic TDP-43, synergize to accelerate motor decline in mice"],"prefix":"10.1016","volume":"384","author":[{"given":"Kelsey L.","family":"Krus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Morales","family":"Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Milbrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Joseph","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"DiAntonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.expneurol.2024.115068_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000923","article-title":"Increased placental mitochondrial fusion in gestational diabetes mellitus: an adaptive mechanism to optimize feto-placental metabolic homeostasis?","volume":"8","author":"Abbade","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.expneurol.2024.115068_bb0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2011.02.060","article-title":"Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome","volume":"1394","author":"Alves","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.115068_bb0015","article-title":"TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS\/FTD and related disorders","author":"Arnold","year":"2024","journal-title":"BioRxiv"},{"issue":"6637","key":"10.1016\/j.expneurol.2024.115068_bb0020","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.abq5622","article-title":"Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies","volume":"379","author":"Baughn","year":"2023","journal-title":"Science (New York, N.Y.)"},{"issue":"43","key":"10.1016\/j.expneurol.2024.115068_bb0025","doi-asserted-by":"crossref","first-page":"E952","DOI":"10.1073\/pnas.1104969108","article-title":"Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3\/atypical protein kinase C (aPKC) signaling","volume":"108","author":"Beirowski","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.expneurol.2024.115068_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157781","article-title":"Tdp-43 and inflammation: implications for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"22","author":"Bright","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115068_bb0035","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-022-02412-9","article-title":"Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis","volume":"143","author":"Broadhead","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2024.115068_bb0040","article-title":"TDP-43 loss induces extensive cryptic polyadenylation in ALS\/FTD","author":"Bryce-Smith","year":"2024","journal-title":"BioRxiv"},{"issue":"1","key":"10.1016\/j.expneurol.2024.115068_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2024.115068_bb0050","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10107","key":"10.1016\/j.expneurol.2024.115068_bb0055","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.expneurol.2024.115068_bib207","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/dds205","article-title":"The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth","volume":"21","author":"Fallini","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"Pt 12","key":"10.1016\/j.expneurol.2024.115068_bb0060","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/brain\/aww251","article-title":"Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice","volume":"139","author":"Geisler","year":"2016","journal-title":"Brain"},{"issue":"42","key":"10.1016\/j.expneurol.2024.115068_bb0065","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2024-11.2011","article-title":"Stathmin is required for stability of the drosophila neuromuscular junction","volume":"31","author":"Graf","year":"2011","journal-title":"J. Neurosci."},{"issue":"18","key":"10.1016\/j.expneurol.2024.115068_bb0070","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/hmg\/ddz141","article-title":"Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis","volume":"28","author":"Guerrero","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115068_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01224-4","article-title":"Reappraisal of metabolic dysfunction in neurodegeneration: focus on mitochondrial function and calcium signaling","volume":"9","author":"Jadiya","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2024.115068_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-016-0144-x","article-title":"Tdp-43 cryptic exons are highly variable between cell types","author":"Jeong","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2024.115068_bb0085","article-title":"Loss of mouse Stmn2 function causes motor neuropathy","author":"Juan","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2024.115068_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-018-0300-4","article-title":"ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair","author":"Klim","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115068_bb0095","article-title":"Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy","author":"Krus","year":"2022","journal-title":"BioRxiv"},{"issue":"12","key":"10.1016\/j.expneurol.2024.115068_bb0100","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.260490","article-title":"SCG10 is required for peripheral axon maintenance and regeneration in mice","volume":"136","author":"Li","year":"2023","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.expneurol.2024.115068_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/science.aab0983","article-title":"TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD","author":"Ling","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2024.115068_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in als and FTD: disrupted RNA and protein homeostasis","author":"Ling","year":"2013","journal-title":"In Neuron"},{"issue":"1","key":"10.1016\/j.expneurol.2024.115068_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-023-01496-0","article-title":"Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation","volume":"27","author":"L\u00f3pez-Erauskin","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"7899","key":"10.1016\/j.expneurol.2024.115068_bb0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","article-title":"TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.expneurol.2024.115068_bb0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend. Med."},{"key":"10.1016\/j.expneurol.2024.115068_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-018-0293-z","article-title":"Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration","author":"Melamed","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115068_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/neu.20295","article-title":"SCG10, a microtubule destabilizing factor, stimulates the neurite outgrowth by modulating microtubule dynamics in rat hippocampal primary cultured neurons","author":"Morii","year":"2006","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.expneurol.2024.115068_bb0140","author":"National Institute of Health"},{"key":"10.1016\/j.expneurol.2024.115068_bb0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fncel.2011.00026","article-title":"Gender-specific mechanism of synaptic impairment and its prevention by GCSF in a mouse model of ALS","volume":"5","author":"Naumenko","year":"2011","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115068_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2024.115068_bb0155","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3304-17.2018","article-title":"Dysregulation of NAD+ metabolism induces a Schwann cell dedifferentiation program","author":"Sasaki","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115068_bb0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1216204109","article-title":"SCG10 is a JNK target in the axonal degeneration pathway","author":"Shin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.expneurol.2024.115068_bib206","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1218311110","article-title":"Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth","volume":"110","author":"Schmid","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.expneurol.2024.115068_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2013.11.007","article-title":"Dynamic regulation of SCG10 in regenerating axons after injury","volume":"252","author":"Shin","year":"2014","journal-title":"Exp. Neurol."},{"issue":"5870","key":"10.1016\/j.expneurol.2024.115068_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.expneurol.2024.115068_bb0175","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddt319","article-title":"The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons","volume":"22","author":"Wang","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.expneurol.2024.115068_bb0180","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.4130","article-title":"The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2024.115068_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymthe.2016.10.013","article-title":"Motor-coordinative and cognitive dysfunction caused by mutant TDP-43 could be reversed by inhibiting its mitochondrial localization","volume":"25","author":"Wang","year":"2017","journal-title":"Mol. Therapy: J. Am. Soc. Gene Therapy"},{"key":"10.1016\/j.expneurol.2024.115068_bb0190","article-title":"TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD","author":"White","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115068_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2024.115068_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102228","article-title":"Sex biology in amyotrophic lateral sclerosis","volume":"95","author":"Zamani","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2024.115068_bb0205","article-title":"TDP-43 nuclear loss in FTD\/ALS causes widespread alternative polyadenylation changes","author":"Zeng","year":"2024","journal-title":"BioRxiv"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624003947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624003947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:34:24Z","timestamp":1764840864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488624003947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"alternative-id":["S0014488624003947"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115068","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two cardinal features of ALS, reduced STMN2 and pathogenic TDP-43, synergize to accelerate motor decline in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115068"}}